Telos Rx vs BreezeMeds: Pricing, meds, and regulatory differences

Quick verdict: For lower advertised starting prices on compounded GLP-1 injections, Telos Rx undercuts BreezeMeds, while BreezeMeds shows a wider set of listed product forms including oral options. This Telos Rx vs BreezeMeds comparison highlights pricing, product form, compounded status and transparency so you can decide which matches your priorities.

See Telos Rx pricing and meds

How the two providers differ on starting price and offers

Telos Rx lists compounded semaglutide as low as $99 per month and tirzepatide as low as $139 per month, with listed reference prices such as $299 and $399 appearing in source details and a note that your price depends on your plan. BreezeMeds lists semaglutide injection starting at $199 per month and tirzepatide injection starting at $299, and also displays oral semaglutide and oral tirzepatide from $399. A separate $169 figure appears on BreezeMeds without clear product association.

View BreezeMeds starting prices

Primary differences organized by evidence

1) Price and advertised starting rates

Telos Rx advertises semaglutide from $99 and tirzepatide from $139 when approved by a licensed provider. BreezeMeds advertises higher starting figures for injectable options: semaglutide from $199 and tirzepatide from $299, and lists oral options from $399. The sources preserve qualifiers: prices apply if a licensed provider approves you, and Telos Rx notes “as low as” pricing.

Check Telos Rx starting rates

2) Medication forms and product range

Both providers offer semaglutide and tirzepatide. Telos Rx emphasizes compounded semaglutide and compounded tirzepatide prescribed online. BreezeMeds lists injectable semaglutide and tirzepatide and also displays oral semaglutide and oral tirzepatide options. If oral formulations matter to you, BreezeMeds’ captured evidence shows oral listings at higher starting prices.

3) Compounded status and regulatory notes

The Telos Rx source repeatedly states semaglutide and tirzepatide are compounded medications, prescription-only, and prescribed only after review by a US-licensed provider, and it includes the regulatory note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. BreezeMeds’ captured evidence flags that medication-specific approval status must be confirmed and that compounded and branded products are not interchangeable. Both sources instruct readers to confirm compounding and approval details.

4) Transparency and unclear items

Telos Rx includes multiple price figures and notes “your price depends on your plan” and “cancel anytime, no penalties.” BreezeMeds displays a variety of starting prices and an unexplained $169 figure; the source notes that the $169 offer is not clearly tied to a product and that fees and billing commitments were not fully visible. Neither source supplies a complete FAQ in the captured evidence.

Comparison table: Telos Rx vs BreezeMeds

Criteria	Telos Rx	BreezeMeds
Starting price (semaglutide)	As low as $99 per month	Starting at $199 per month
Starting price (tirzepatide)	As low as $139 per month	Starting at $299 per month
Medication forms shown	Compounded semaglutide and tirzepatide (injections indicated)	Injectable semaglutide and tirzepatide; oral semaglutide and tirzepatide listed from $399
Compounded status	Compounded medications; not FDA-approved; prescribed after US-licensed provider review	Compounding and approval status require confirmation; not interchangeable with branded products
Transparency and unclear items	Notes prices depend on plan; cancel anytime language captured	Displays multiple starting prices and an unexplained $169 figure; fees not fully visible
Cancellation and billing	Cancel anytime, no penalties (captured)	Fees and billing commitments not fully visible in captured evidence

What the evidence does not supply

The captured source materials do not supply full state availability lists, insurance acceptance details, complete FAQs, or verified pharmacy and renewal terms. Any additional claims about clinical outcomes, insurance coverage, or unlisted fees are not provided in the captured evidence and should be confirmed directly with each provider.

Confirm BreezeMeds product details

Final comparison and how to choose

In a direct Telos Rx vs BreezeMeds comparison based on captured evidence, Telos Rx advertises lower starting prices for compounded semaglutide and tirzepatide and emphasizes US-licensed provider review and compounded status. BreezeMeds lists higher starting prices for injectable options but also displays oral formulations from $399 and includes discreet shipping and personalized planning in captured bullets, while noting an unclear $169 figure.

Evaluate Telos Rx treatment options

Choose Telos Rx if you prioritize lower advertised starting prices on compounded semaglutide or tirzepatide and accept that these are compounded medications prescribed after US-licensed provider review.

Choose BreezeMeds if you prioritize seeing oral formulation listings and a captured emphasis on discreet shipping and a broader listed product set, but be prepared to confirm which prices apply and what the unexplained $169 figure refers to.